Answers are grounded in this paper and cite their sources.
SUMMARY Effective fluid therapy is a main stay in the ma nagement of the critically ill patient. The ideal kind of volume replacement in this situation still remains achallenge. To treat hypovolemia, colloids are widely used, and the natural colloid h u man albumin is still preferred for volume therapy in several centers. H oweve r, most studies do not show any bene fits of using albumin with regard to hemodyna mics, organ function or side effects (e. g. hemostasis, renalfunction). Alternative plasma substitutes such as synthetic colloids are associated with some beneficial effects compared to albumin administration (e. g. improved splanchnic perfusion). Given albumin's costs, its use does not appear to be justified, and other solutions (e. g. synthetic colloids) are attractive alternatives. Inspite of some theoretical adva n tages based on our current knowledge, use of albumin cannot be recommended and should be completely avoided.
No takes yet. Share an insight, caveat, or question.
Joachim Bold (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: